GreenMJHarrisFLaurensKR, et al. (2018) Cohort profile: The New South Wales Child Development Study (NSW-CDS)-Wave 2 (child age 13 years). International Journal of Epidemiology47: 1396–1397.
2.
KarangesEAStephensonCPMcGregorIS (2014) Longitudinal trends in the dispensing of psychotropic medications in Australia from 2009–2012: Focus on children, adolescents and prescriber specialty. Australian and New Zealand Journal of Psychiatry48: 917–931.
3.
KessingLVZiersenSCCaspiA, et al. (2023) Lifetime incidence of treated mental health disorders and psychotropic drug prescriptions and associated socioeconomic functioning. JAMA Psychiatry80: 1000–1008.
4.
KovessVChoppinSGaoF, et al. (2015) Psychotropic medication use in French children and adolescents. Journal of Child and Adolescent Psychopharmacology25: 168–175.
PiovaniDClavennaABonatiM (2019) Prescription prevalence of psychotropic drugs in children and adolescents: An analysis of international data. European Journal of Clinical Pharmacology75(10): 1333–1346.
7.
PiovaniDClavennaACartabiaM, et al. (2016) Psychotropic medicine prescriptions in Italian youths: A multiregional study. European Child & Adolescent Psychiatry25(3): 235–245.
8.
WoodSJIlomäkiJGouldJ, et al. (2023) Dispensing of psychotropic medications to Australian children and adolescents before and during the COVID-19 pandemic, 2013–2021: A retrospective cohort study. Medical Journal of Australia219: 18–25.
